Key points are not available for this paper at this time.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
“One year after their procedure, patients who were randomized to wear a heart monitor for 14 days had fewer life-threatening CV events than those who were not monitored, with the researchers observing that ambulatory monitoring did not lead to overtreatment or unnecessary pacemaker implantation.”
Lilly et al. (Wed,) studied this question.